Mercado de diagnóstico de trasplantes: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00003076
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 150
Buy Now

Se estima que el tamaño del mercado de diagnóstico de trasplantes alcanzará los 1.542,89 millones de dólares en 2027, frente a los 789,88 millones de dólares de 2018; se estima que crecerá a una tasa compuesta anual del 7,9 % durante 2019-2027.

El diagnóstico de trasplante se refiere a las pruebas de diagnóstico realizadas en los órganos que se van a trasplantar. Estas pruebas se realizan antes o después del trasplante. Algunas de las técnicas comunes utilizadas en el diagnóstico de trasplantes son ensayos moleculares basados en secuencias, ensayos moleculares basados en PCR y ensayos no moleculares en ciertos casos. El diagnóstico del trasplante es un factor esencial en el trasplante de órganos, ya que evita complicaciones adicionales que podrían ocurrir después del procedimiento de trasplante.

El crecimiento del mercado de diagnóstico de trasplantes se atribuye a la creciente prevalencia de enfermedades cardiovasculares y al crecimiento significativo de la industria biotecnológica. Sin embargo, las costosas cirugías de trasplante de órganos pueden obstaculizar el crecimiento del mercado.

regiones lucrativas para el mercado de diagnóstico de trasplantes



Perspectivas del mercado

Prevalencia creciente de enfermedades cardiovasculares

Las ECV son la principal causa de muerte en todo el mundo. El envejecimiento de la población comúnmente muestra la alteración estructural y funcional de la acumulación de vasos a lo largo de su vida. Por tanto, aumenta el riesgo de desarrollar enfermedades cardiovasculares. Según el Colegio Americano de Cardiología, se afirma que las enfermedades cardiovasculares contribuyen con casi 800.000 muertes en los EE. UU., lo que es aproximadamente una de cada tres muertes. La enfermedad coronaria (CHD) contribuye a la mayoría de las muertes por ECV, seguida por los accidentes cerebrovasculares y la insuficiencia cardíaca. Casi más de 90 millones de estadounidenses son diagnosticados con enfermedades cardiovasculares. Además, se afirma que a nivel mundial las enfermedades cardiovasculares contribuyen alrededor del 31% de todas las muertes y se espera que el costo de las ECV sea de aproximadamente 1.044 mil millones de dólares para 2030.

 < /p>

Las ECV representan el 45,0% de todas las muertes en Europa y el 37,0% de todas las muertes en la UE. Debido a esto, es probable que la necesidad de diagnósticos de trasplantes para trasplantes de órganos impulse el mercado durante el período de pronóstico.

Información basada en productos y servicios

< p>El mercado mundial de diagnóstico de trasplantes, basado en productos y servicios, se segmenta en instrumentos, reactivos y componentes. consumibles y software y accesorios. servicios. Los reactivos y El segmento de consumibles fue el segmento más grande entre los subsegmentos de productos y servicios en el mercado de diagnóstico de trasplantes en 2018. Sin embargo, el software y los consumibles; Se espera que el segmento de servicios experimente un crecimiento en su demanda a la tasa compuesta anual más rápida del 9,6 % durante 2019-2027.

Información basada en tipos

El El mercado mundial de diagnóstico de trasplantes, según el tipo, se segmenta en trasplante de órganos sólidos, trasplante de tejidos blandos y trasplante de células madre. El segmento de trasplante de órganos sólidos tuvo la mayor participación del mercado de diagnóstico de trasplantes en 2018 y se prevé que continúe teniendo el mercado más grande durante el período de pronóstico.

Basado en tecnología Insights

El mercado mundial de diagnóstico de trasplantes, basado en la tecnología, se segmenta en ensayos moleculares y ensayos no moleculares. En 2018, el segmento de sistemas de ensayos moleculares tuvo una mayor participación de mercado y se espera que experimente un crecimiento en su demanda a una tasa compuesta anual más rápida del 9,5 % durante 2019-2027.

< h3>Información basada en aplicaciones

El mercado global de diagnóstico de trasplantes, basado en la aplicación, se segmenta en aplicaciones de diagnóstico y aplicaciones de investigación. En 2018, el segmento de aplicaciones de diagnóstico tuvo una mayor participación del mercado y se espera que crezca a un ritmo más rápido durante los próximos años.

Perspectivas estratégicas

Los lanzamientos y aprobaciones de productos son estrategias comúnmente adoptadas por las empresas para ampliar su presencia global y sus carteras de productos. Además, los actores del mercado de diagnóstico de trasplantes se centran en la estrategia de asociación para ampliar su clientela, lo que, a su vez, les permite mantener su marca en todo el mundo.

Empresa Perfiles

  • BIO-RAD LABORATORIES, INC
  • BIOMÉRIEUX SA
  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • QIAGEN NV
  • F. HOFFMANN-LA ROCHE LTD.
  • HOLOGIC INC.
  • LUMINEX CORPORATION
  • OMIXON INC.
  • ABBOTT
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are transplant diagnostics?

Transplant diagnostics refers to the diagnostics tests that are conducted on the organs that are meant to be transplanted. These tests are performed pre and post transplantation.

What are major common techniques used in transplant diagnostics?

Some of the common techniques used in transplant diagnostics include, sequence based molecular assays, and PCR based molecular assays and also non-molecular assays in certain cases.

Who are the key players in the transplant diagnostics market?

The major key players are Abbott, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Omixon Inc., Hologic Inc., Luminex Corporation, F. Hoffmann-La Roche Ltd, bioMérieux SA.

The List of Companies
  1. Thermo Fisher Scientific Inc.
  2. Abbott
  3. Illumina, Inc.
  4. F. Hoffmann-La Roche Ltd
  5. Bio-Rad Laboratories, Inc.
  6. bioMérieux SA
  7. QIAGEN
  8. Hologic Inc.
  9. Luminex Corporation
  10. Omixon Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports